Latest Funding News

Assetora Australia Limited has been officially appointed as the Responsible Entity of the DomaCom Fund, lifting previous restrictions and paving the way for renewed investment activity and secondary market trading.

Inventis Limited has placed its commercial furniture division into voluntary administration, triggering a default event with its lender and prompting negotiations on financial restructuring.

Papyrus Australia has successfully expanded its banana fibre technology to produce boards and flat paper products, while advancing a promising joint venture in Vietnam for high-volume production.

Papyrus Australia reported a modest net operating cash outflow of $39,000 for May 2025, maintaining a solid cash position supported by available loan facilities that extend its funding runway to over 16 months.

The Takeovers Panel has received a contentious application challenging Keybridge Capital’s role in the Yowie takeover bid, spotlighting conflicts of interest tied to WAM Active’s influence. Interim orders were declined, leaving the dispute unresolved as a critical shareholder meeting unfolds.

Capricorn Metals has fully repaid its remaining $50 million corporate debt ahead of schedule, positioning itself as debt and gold hedging free with strong cash reserves to back growth projects.

Global X Management (AUS) Limited has updated the estimated distribution for its Ultra Long Nasdaq 100 Complex ETF, setting it at just over 54 cents per unit for the June 2025 period. Key dates for distribution and dividend reinvestment plan participation are now confirmed.

Mineral Commodities Ltd has extended the maturity date of its A$2.4 million convertible loan facility, tying repayment timing to the potential sale of its Skaland asset. This move provides the company with greater financial flexibility as it navigates strategic asset sales.

Andromeda Metals has launched a $5 million capital raising via a Placement, accompanied by Placement and Broker Options, to advance its flagship Great White Project and High Purity Alumina development.

Microba Life Sciences invites eligible shareholders to participate in a $2 million Share Purchase Plan at $0.09 per share, matching recent institutional pricing and including free attaching options. The capital raise aims to accelerate clinical adoption and push the company towards regional break-even.

Microba Life Sciences has announced a $14.5 million capital raising, including a $2 million fully underwritten Securities Purchase Plan (SPP) and a $12.5 million Placement, aimed at fast-tracking commercialisation of its microbiome diagnostic tests in Australia and the UK.

State Street Global Advisors has announced a substantial cash distribution for the SPDR S&P/ASX 200 ESG ETF, reflecting the fund’s income and tax attributes for the year ending June 2025.